Mark K. Oki
Equibles does not estimate personal net worth.
About Mark K. Oki
Mark K. Oki was last confirmed as CFO at Aytu Biopharma, Inc (AYTU) in a filing dated March 28, 2025. Earlier roles on record: CFO at Aytu Biopharma, Inc (AYTU) until November 11, 2024. Aytu Biopharma, Inc reported in an 8-K filed November 13, 2024 that Mark K. Oki was terminated as Chief Financial Officer, effective November 11, 2024. The proxy statement of Aytu Biopharma, Inc reports total compensation of $238,387 for Mark K. Oki in fiscal 2025, including a base salary of $238,387. Disclosed compensation is on record for 4 fiscal years.
“On November 11, 2024, Mark K. Oki was terminated as Chief Financial Officer of the Company.”
Affiliation history
-
Start not stated–2025-03-28
Last confirmed by a filing; no departure on record
-
Start not stated–2024-11-11
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aytu Biopharma, Inc (AYTU) | Former Chief Financial Officer, Corporate Secretary and Treasurer | $238,387 | $238,387 |
| 2024 | Aytu Biopharma, Inc (AYTU) | Former Chief Financial Officer, Corporate Secretary and Treasurer | $427,450 | $584,669 |
| 2023 | Aytu Biopharma, Inc (AYTU) | Former Chief Financial Officer, Corporate Secretary and Treasurer | $415,000 | $522,840 |
| 2022 | Aytu Biopharma, Inc (AYTU) | Chief Financial Officer, Corporate Secretary and Treasurer since January 2022 | $183,558 | $368,558 |